GSK PLC completed the spinoff of its consumer-healthcare business, a bet thatwill help accelerate growth at the pharmaceuticals giant.
The new stand-alone company, called Haleon PLC, fetched a market value of about £30.5 billion, equivalent to $36.4 billion, at its stock-market debut Monday. The listing is one of the largest in London for years and the biggest corporate change for GSK—until recently called GlaxoSmithKline–since it was formed through a megamerger in 2000.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: